Effect of Docosahexaenoic Acid on ROP in premature newbor
Phase 3
Completed
- Conditions
- Retinopathy of prematurity.H35.1Retinopathy of prematurity
- Registration Number
- IRCT20211226053528N1
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 124
Inclusion Criteria
Obtaining parental consent to participate in the study
Premature newborn weighing less than1500 gr
Exclusion Criteria
Infants with asphyxia (umbilical cord pH less than 7 and BE less than -16)
IUGR infants
Definitive sepsis (positive blood culture),
Newborns with severe congenital chromosomal abnormalities
Newborns with congenital heart disease
Infants with metabolic diseases
Newborns with hypotension need vasodilators
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Retinopathy stage (based on disease severity). Timepoint: before intervention and 1month after intervention. Method of measurement: Based on the severity of the disease (1-5 stages) by an ophthalmologist.
- Secondary Outcome Measures
Name Time Method